The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
This Month’s HighlightsFull Access

This Month’s Highlights

Published Online:https://doi.org/10.1176/appi.ps.667TMH

Special Section on RAISE and Other Early Intervention Services

Four articles, two brief reports, and three columns in this issue focus on coordinated specialty care programs for individuals experiencing early psychosis. Such programs, which seek to change the trajectory and prognosis of schizophrenia through comprehensive and aggressive treatment in the earliest stages of illness, have been widely implemented in other countries, but not in the United States. In 2008, the National Institute of Mental Health (NIMH) announced the RAISE project (Recovery After an Initial Schizophrenia Episode), later awarding contracts to two research groups to develop and test potential interventions. The special section features reports from both groups. In Taking Issue, Amy B. Goldstein, Ph.D., and her NIMH colleagues describe the ways in which each report in the special section addresses implementation challenges identified when RAISE was launched (page Original article: 665). In the lead article, Kim T. Mueser, Ph.D., and colleagues from one of the NIMH-funded groups describe the intervention they developed, known as the NAVIGATE program. Core services include family education, individual resiliency training, supported employment and education, and individualized medication treatment (page Original article: 681). In the second article, Lisa B. Dixon, M.D., M.P.H., principal investigator for the other NIMH-funded group, and her colleagues provide an overview of services included in the intervention they developed—the RAISE Connection Program. These authors also present outcome data on functioning, symptoms, and remission among clients who received services for up to two years at Connection sites in Baltimore and New York City (page Original article: 692). Because engagement is critical to the effectiveness of these programs, researchers at the Baltimore and New York sites examined data from semistructured interviews with clients—both those who were well engaged and those who were not. As Alicia Lucksted, Ph.D., and colleagues report, Connection’s focus on life goals was a central factor in engaging clients. Most interviewees were under age 25, and their engagement hinged substantially on Connection’s nonclinical services, such as supported education and employment (page Original article: 700). In a third article, Vinod H. Srihari, M.D., and colleagues present findings from a controlled trial of STEP (Specialized Treatment Early in Psychosis). STEP, which is not part of the RAISE initiative, was established in 2006 by the Connecticut Mental Health Center. After one year, STEP participants had significantly fewer and shorter hospital stays than those in usual treatment and demonstrated better vocational engagement (page Original article: 706). Of the three columns in the special section, two are from RAISE researchers associated with the Connection Program. In Research & Services Partnerships, Susan M. Essock, Ph.D., and coauthors describe the Connection Program as a partnership involving researchers and state mental health authorities. The authors explain why states are interested in first-episode services and describe the development of the partnership, financing mechanisms, and plans to add teams in Maryland and New York (page Original article: 672). As these programs are implemented more widely, new teams’ fidelity to the intervention is essential. In the Best Practices column, Dr. Essock and colleagues present a practical approach to fidelity monitoring that they developed for the Connection Program—one that uses routinely available administrative data as well as information from client interviews (page Original article: 675). Widespread dissemination will also require a funding mechanism that not only is compatible with approaches already used by payers but also generates incentives for providers. In Economic Grand Rounds, Richard G. Frank, Ph.D., and colleagues propose a funding model with three components and describe how such a model might be implemented (page Original article: 678). Two brief reports complete the special section. The first, by Jean Addington, Ph.D., and others associated with the NAVIGATE program, presents findings from a study that examined duration of untreated psychosis (DUP) among community mental health center clients. Median DUP was 74 weeks, and two-thirds of participants had DUP of greater than six months (page Original article: 754). Finally, in a two-year study of patients receiving first-episode services in Montreal, Clairélaine Ouellet-Plamondon, M.D., F.R.C.P.C., and colleagues found high rates of disengagement among immigrants, even though their medication adherence was similar to that of nonimmigrants (page Original article: 758).

Briefly Noted

As Medicaid programs transition from branded second-generation antipsychotics to generics, expenditures for these drugs could decrease by more than 75%, according to a forecasting study based on analyses of 2008–2011 Medicaid data (page Original article: 719).

This month’s Open Forum describes SAMHSA’s Recovery to Practice project, a workforce collaborative to increase clinicians’ skills in delivering evidence-based, recovery-oriented services (page Original article: 751).